Pfizer, Moderna post data backing COVID shots (PFE:NYSE)
Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) announced clinical trial data to reaffirm the effectiveness and safety of their messenger RNA-based COVID shots on Tuesday after President Donald Trump called on the vaccine makers to justify their success earlier this month. New ...